Article metrics

Download PDFPDF

Original research
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

 

Online download statistics by month:

Online download statistics by month: April 2020 to August 2020

AbstractFullPdf
Apr 2020276276163
May 202022022059
Jun 2020989831
Jul 2020696926
Aug 2020363615
Total699699294